Cano Health (Cano Health) ROCE % : -433.56% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Cano Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cano Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -433.56%.

Cano Health ROCE % Historical Data

The historical data trend for Cano Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cano Health ROCE % Chart

Cano Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-6.66

-5.17

-19.65

-149.52

Cano Health Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial											-60.16	-8.60	-63.44	-166.83	-433.56

Cano Health ROCE % Calculation

Cano Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-985.968	/	( ( (1928.927 - 208.438)	+	(1013.739 - 1415.426) )	/ 2 )
	=	-985.968	/	( (1720.489	+	-401.687)	/ 2 )
	=	-985.968	/	659.401
	=	-149.52 %

Cano Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-963.176	/	( ( (1211.931 - 365.934)	+	(1013.739 - 1415.426) )	/ 2 )
	=	-963.176	/	( ( 845.997	+	-401.687 )	/ 2 )
	=	-963.176	/	222.155
	=	-433.56 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Cano Health (OTCPK:CANOQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cano Health ROCE % Related Terms

Thank you for viewing the detailed overview of Cano Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cano Health (Cano Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cano Health Inc (OTCPK:CANOQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9725 NW 117th Avenue, Suite 200, Miami, FL, USA, 33178

Website

https://www.canohealth.com

Cano Health Inc operates value-based primary care centers and supports affiliated medical practices that specialize in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico.

Executives

Elliot Cooperstone	director, 10 percent owner	C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Eladio Gil	officer: Interim CFO	9725 NW 17TH AVENUE, SUITE 200, MIAMI FL 33178
Robert Camerlinck	officer: Chief Operating Officer	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Richard Aguilar	officer: Chief Clinical Officer	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Mark D. Kent	officer: Interim CEO	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
David J Armstrong	officer: See Remarks	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Brian D Koppy	officer: Chief Financial Officer	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Lewis Gold	director	1235 SPANISH RIVER ROAD, BOCA RATON FL 33432
Marlow Hernandez	director, officer: See Remarks	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Solomon D Trujillo	director	1000 NICOLLET MALL, TPS-3255, MINNEAPOLIS MN 55403
Alan Muney	director	48 MONROE TURNPIKE, TRUMBULL CT 06611
Kim M Rivera	director	601 HAWAII ST, EL SEGUNDO CA 90245
Itc Rumba, Llc	10 percent owner	444 MADISON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jacqueline Guichelaar	director	C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Angel L Morales	director	C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178